US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

ANI Pharmaceuticals

67.52

-0.7700-1.13%

Post-market: 67.520.00000.00%18:30 EDT

Volume:698.16K

Turnover:46.74M

Market Cap:1.47B

PE:-147.97

High:68.40

Open:66.02

Low:65.13

Close:68.29

Loading ...

Overview Company News Filings

Piper Sandler Initiates Coverage on ANI Pharmaceuticals With Overweight Rating, $68 Price Target

MT Newswires Live

Buy Rating Affirmed: ANI Pharmaceuticals’ Transition to High-Margin Rare Disease Brands Fuels Growth Potential

ANI Pharmaceuticals initiated with an Overweight at Piper Sandler

U.S. RESEARCH ROUNDUP- ANI Pharmaceuticals, Deere & Co, Zoetis

ANI Pharmaceuticals Inc : Piper Sandler Initiates Coverage With Overweight Rating; Price Target $68

THOMSON REUTERS

PTCT Stock Rises on Positive Updates on Friedreich Ataxia Program

SAGE's Dalzanemdor Fails to Meet Goal in Alzheimer's Disease Study

Wall Street Analysts Predict a 42.98% Upside in ANI (ANIP): Here's What You Should Know

SLNO Stock Rises on Upbeat Regulatory Update on PWS Drug NDA

NTLA Begins Phase III Study on Hereditary Angioedema Candidate

AstraZeneca Inks Agreement to Boost Cardiovascular Pipeline

SRRK Stock Soars as Muscle Disease Drug Meets Phase III Study Goal

Johnson & Johnson Scraps Phase II Study on Antiviral for Dengue Virus

Sage Therapeutics Stock Down Almost 40% in 3 Months: Here's Why

ONCY Stock Up on Regulatory Update From Breast Cancer Program

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ANIP/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ANIP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ANIP\",,,,,undefined,":{"symbol":"ANIP","market":"US","secType":"STK","nameCN":"ANI Pharmaceuticals","latestPrice":67.52,"timestamp":1743796800000,"preClose":68.29,"halted":0,"volume":698163,"hourTrading":{"tag":"盘后","latestPrice":67.52,"preClose":67.52,"latestTime":"18:30 EDT","volume":5551,"amount":374782.93,"timestamp":1743805813557},"delay":0,"floatShares":16742600,"shares":21773510,"eps":-0.456324,"marketStatus":"Market Closed","change":-0.77,"latestTime":"04-04 16:00:00 EDT","open":66.02,"high":68.4,"low":65.13,"amount":46741377.52167,"amplitude":0.047884,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.456324,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1744012800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1064980800000,"exchange":"NASDAQ","adjPreClose":68.29,"preHourTrading":{"tag":"盘前","latestPrice":66.6,"preClose":68.29,"latestTime":"09:29 EDT","volume":509,"amount":34379.868005,"timestamp":1743773355118},"postHourTrading":{"tag":"盘后","latestPrice":67.52,"preClose":67.52,"latestTime":"18:30 EDT","volume":5551,"amount":374782.93,"timestamp":1743805813557},"volumeRatio":1.9599626519368698,"impliedVol":0.6354,"impliedVolPercentile":0.9562},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ANIP\",,,,,undefined,":{"symbol":"ANIP","floatShares":16742600,"roa":"0.84%","roe":"-4.18%","lyrEps":0.859674,"volumeRatio":1.9599626519368698,"shares":21773510,"dividePrice":0,"high":68.4,"amplitude":0.047884,"preClose":68.29,"low":65.13,"week52Low":52.5,"pbRate":"3.64","psRate":"2.39","week52High":70,"institutionHeld":0.9147,"latestPrice":67.52,"eps":-0.456324,"divideRate":0,"volume":698163,"delay":0,"ttmEps":-0.456324,"open":66.02,"prevYearClose":55.28,"prevWeekClose":67.61,"prevMonthClose":66.95,"prevQuarterClose":66.95,"fiveDayClose":67.61,"twentyDayClose":60.62,"sixtyDayClose":54.38},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ANIP\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2474098521","title":"Piper Sandler Initiates Coverage on ANI Pharmaceuticals With Overweight Rating, $68 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2474098521","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474098521?lang=en_us&edition=fundamental","pubTime":"2024-10-11 20:00","pubTimestamp":1728648024,"startTime":"0","endTime":"0","summary":"ANI Pharmaceuticals (ANIP) has an average rating of outperform and price targets ranging from $60 to $94, according to analysts polled by Capital IQ.(MT Newswires covers equity, commodity and economic","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ANIP"],"gpt_icon":0},{"id":"2474050630","title":"Buy Rating Affirmed: ANI Pharmaceuticals’ Transition to High-Margin Rare Disease Brands Fuels Growth Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2474050630","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474050630?lang=en_us&edition=fundamental","pubTime":"2024-10-11 16:58","pubTimestamp":1728637132,"startTime":"0","endTime":"0","summary":"ANI Pharmaceuticals (ANIP) has received a new Buy rating, initiated by Piper Sandler analyst, David Amsellem. David Amsellem has given his Buy rati...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/buy-rating-affirmed-ani-pharmaceuticals-transition-to-high-margin-rare-disease-brands-fuels-growth-potential?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/buy-rating-affirmed-ani-pharmaceuticals-transition-to-high-margin-rare-disease-brands-fuels-growth-potential?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ANIP"],"gpt_icon":0},{"id":"2474508050","title":"ANI Pharmaceuticals initiated with an Overweight at Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2474508050","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474508050?lang=en_us&edition=fundamental","pubTime":"2024-10-11 16:50","pubTimestamp":1728636617,"startTime":"0","endTime":"0","summary":"Piper Sandler initiated coverage of ANI Pharmaceuticals with an Overweight rating and $68 price target ANI’s business model has evolved considerabl...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ani-pharmaceuticals-initiated-with-an-overweight-at-piper-sandler?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ani-pharmaceuticals-initiated-with-an-overweight-at-piper-sandler?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ANIP"],"gpt_icon":0},{"id":"2474059655","title":"U.S. RESEARCH ROUNDUP- ANI Pharmaceuticals, Deere & Co, Zoetis","url":"https://stock-news.laohu8.com/highlight/detail?id=2474059655","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474059655?lang=en_us&edition=fundamental","pubTime":"2024-10-11 15:47","pubTimestamp":1728632827,"startTime":"0","endTime":"0","summary":"Oct 11 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including ANI Pharmaceuticals, Deere & Co and Zoetis on Friday.    HIGHLIGH","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2271345857.HKD","BK4082","LU2264538146.SGD","DE","EMN","BK4539","LU1989763427.SGD","IE00BMPRXN33.USD","DAL","ARHS","DPZ","LU0058720904.USD","LU0128525689.USD","LU1983299246.USD","HUN","IE0009356076.USD","LU1852331112.SGD","LU0314104364.USD","LU1989764664.SGD","NAPA","ISRG","LU1804176565.USD","CE","SGXZ23171101.USD","LU1880398471.USD","FLUT","ANIP","LU0061475181.USD","LU0081259029.USD","LU0690374961.EUR","LU0097036916.USD","LU0158827948.USD","WLK","XNCR","BK4500","LU0289739343.SGD","LU1989763690.USD","EWTX","ZTS","LU0971096721.USD","LU0158827781.USD","BK4152","IDXX","LU0642271901.SGD","LU0098860793.USD","GB00B4LPDJ14.GBP","CC","LU1868837136.USD","BK4524"],"gpt_icon":1},{"id":"2474038673","title":"ANI Pharmaceuticals Inc : Piper Sandler Initiates Coverage With Overweight Rating; Price Target $68","url":"https://stock-news.laohu8.com/highlight/detail?id=2474038673","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474038673?lang=en_us&edition=fundamental","pubTime":"2024-10-11 11:44","pubTimestamp":1728618242,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241011:nFWN3LN0B4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ANIP"],"gpt_icon":0},{"id":"2474203352","title":"PTCT Stock Rises on Positive Updates on Friedreich Ataxia Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2474203352","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474203352?lang=en_us&edition=fundamental","pubTime":"2024-10-10 01:40","pubTimestamp":1728495600,"startTime":"0","endTime":"0","summary":"PTC Therapeutics, Inc. PTCT announced positive results on two different long-term extension studies on vatiquinone.The company also announced regulatory progress on vatiquinone for the treatment of Friedreich ataxia .Year to date, shares of PTC Therapeutics have risen 48% against the industry’s 4.6% decline.PTCT announced that the pre-specified endpoint for two different FA long-term extension studies was met, with highly statistically significant evidence of durable treatment benefit on disease progression.The primary endpoint of change from baseline in the overall modified Friedreich Ataxia Rating Scale  score did not reach statistical significance. Nonetheless, a statistically significant effect was recorded on the mFARS upright stability subscale, which was a pre-specified endpoint. This subscale is the most relevant and sensitive mFARS component for pediatric and young adults.PTCT plans to submit the new drug application  for vatiquinone for the treatment of FA in December 2024. T","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/.UMP6LIbiG0Pb3tKR9RYYw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1566882a22938942efee3e7508e93e96","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/.UMP6LIbiG0Pb3tKR9RYYw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1566882a22938942efee3e7508e93e96"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ptct-stock-rises-positive-updates-174000628.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ALNY","BK4130","BK4539","FA","LU0889565916.HKD","LU0109394709.USD","PTCT","BK4585","BK4588","BK4007","BK4548","LU0320765992.SGD","ANIP","BK4170","BK4139","MOVE","BK4535"],"gpt_icon":0},{"id":"2474852272","title":"SAGE's Dalzanemdor Fails to Meet Goal in Alzheimer's Disease Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2474852272","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474852272?lang=en_us&edition=fundamental","pubTime":"2024-10-10 00:26","pubTimestamp":1728491160,"startTime":"0","endTime":"0","summary":"Shares of Sage Therapeutics, Inc. SAGE were down 4.3% on Oct. 8 after the company announced disappointing top-line data from the phase II LIGHTWAVE study, which evaluated its neuropsychiatric candidate, dalzanemdor  for treating mild cognitive impairment  and mild dementia in Alzheimer’s Disease . The stock continued to lose another 2.8% in the after-market hours.The double-blind, placebo-controlled LIGHTWAVE study evaluated theeffects of dalzanemdor in participants with MCI or mild dementia due to AD.Data from the study showed that treatment with dalzanemdor failed to demonstrate a statistically significant difference from baseline as compared to placebo on the Wechsler Adult Intelligence Scale Fourth Edition  Coding Test score at day 84. This was the primary endpoint of the 12-week LIGHTWAVE study.Year to date, shares of Sage Therapeutics have plunged 70.3% compared with the industry’s decline of 5.2%.Now that Sage Therapeutics has faced a couple of setbacks with the AD and PD indica","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/b7YQi_HTDu1GkQZqPUqgyw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/59b208c03ab625710a229f805a232093","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/b7YQi_HTDu1GkQZqPUqgyw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/59b208c03ab625710a229f805a232093"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sages-dalzanemdor-fails-meet-goal-162600148.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BWXC8680.SGD","LU1551013342.USD","LU0354030438.USD","IE00BZ1G4Q59.USD","LU0820561818.USD","LU1093756168.USD","LU1674673428.USD","LU1778281490.HKD","SAGE","LU1093756325.SGD","MCI","LU1551013425.SGD","LU0823411888.USD","ADMA","LU0820562030.AUD","LU1169590202.USD","IE00BKVL7J92.USD","LU0689472784.USD","LU1674673691.USD","SG9999001440.SGD","LU0079474960.USD","ANIP","IE00B1XK9C88.USD","LU1496350171.SGD","LU0868494708.USD","BK4566","BK4581","HD","LU0943347566.SGD","BK4533","BK4023","LU0320765646.SGD","LU0354030511.USD","BK4550","LU2756315318.SGD","LU1914381329.SGD","LU0820561909.HKD","ALNY","BK4585","LU1929549753.HKD","BK4534","PD","LU0234572021.USD","LU0942090050.USD","LU2756315664.SGD","BK4504","LU1162221912.USD","BK4567","LU1989772923.USD","BK4083"],"gpt_icon":0},{"id":"2474273708","title":"Wall Street Analysts Predict a 42.98% Upside in ANI (ANIP): Here's  What You Should Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2474273708","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474273708?lang=en_us&edition=fundamental","pubTime":"2024-10-09 21:55","pubTimestamp":1728482105,"startTime":"0","endTime":"0","summary":"ANI Pharmaceuticals  closed the last trading session at $56.79, gaining 2.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $81.20 indicates a 43% upside potential.However, an impressive consensus price target is not the only factor that indicates a potential upside in ANIP. This view is strengthened by the agreement among analysts that the company will report better earnings than what they estimated earlier. Though a positive trend in earnings estimate revisions doesn't give any idea as to how much the stock could surge, it has proven effective in predicting an upside.That said, while investors should not entirely ignore price targets, making an investment decision solely based on them could lead to disappointing ROI. So, price targets should always be treated with","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/nxwFIPS2ImeTQYZMYlnAgg--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1a018a29aef5adbf5b4319f32058e209","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/nxwFIPS2ImeTQYZMYlnAgg--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1a018a29aef5adbf5b4319f32058e209"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/wall-street-analysts-predict-42-135505125.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","ANIP"],"gpt_icon":0},{"id":"2474722280","title":"SLNO Stock Rises on Upbeat Regulatory Update on PWS Drug NDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2474722280","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474722280?lang=en_us&edition=fundamental","pubTime":"2024-10-09 21:33","pubTimestamp":1728480780,"startTime":"0","endTime":"0","summary":"Per SLNO, the Review Division of the FDA has stated that there is no need for an advisory committee meeting for the DCCR NDA at present. However, the regulatory body will continue to consider the potential need for the same during the ongoing review process.Soleno’s lead candidate, DCCR, is an innovative, once-daily, proprietary extended-release dosage form that contains diazoxide choline, the crystalline salt form of diazoxide. Although not approved for treating PWS, the parent molecule, diazoxide, treats a few rare diseases in neonates, infants, children and adults.Year to date, shares of SLNO have rallied 29.1% against the industry’s 5.2% decline.In a previous late-stage study conducted by Levo, carbetocin demonstrated a nominally statistically significant reduction in hyperphagia-related behaviors in PWS patients. Consequently, in the fourth quarter of 2023, Acadia initiated a pivotal phase III COMPASS PWS study evaluating the efficacy and safety of the candidate for the same indic","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/VTpWEp9iphTX3xsYcMogbg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ca9d72216d7bb42fc496430c3df29b41","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/VTpWEp9iphTX3xsYcMogbg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ca9d72216d7bb42fc496430c3df29b41"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/slno-stock-rises-upbeat-regulatory-133300907.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PWS","ANIP","LU2065170008.USD","BK4585","SLNO","BK4588","ALNY","BK4548","ACAD","LU2065169927.USD","LU2065171311.SGD","BK4139","LU2065171402.SGD","BK4007"],"gpt_icon":0},{"id":"2474728402","title":"NTLA Begins Phase III Study on Hereditary Angioedema Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2474728402","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474728402?lang=en_us&edition=fundamental","pubTime":"2024-10-09 01:07","pubTimestamp":1728407220,"startTime":"0","endTime":"0","summary":"Intellia Therapeutics, Inc. NTLA announced that it has initiated the pivotal phase III HAELO study evaluating NTLA-2002 for the treatment of hereditary angioedema .The global double-blind, placebo-controlled study will evaluate the safety and efficacy of NTLA-2002 in adults with Type I or Type II HAE. The primary endpoint of the study is to see the change in number of HAE attacks from week five through week 28 of treatment.Patient screening is currently ongoing in the study.Year to date, shares of Intellia have plunged 41.5% compared with the industry’s decrease of 2.8%.NTLA-2002 is Intellia’s investigational single-dose CRISPR/Cas9 gene-editing therapy, which is being developed as a one-time cure for HAE. It is a rare genetic condition marked by severe inflammatory attacks in various body organs and tissues, which can be painful and even life-threatening.In the past 60 days, estimates for ANI Pharmaceuticals’ 2024 earnings per share have moved up from $4.53 to $4.81. Earnings per shar","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/b7YQi_HTDu1GkQZqPUqgyw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/59b208c03ab625710a229f805a232093","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/b7YQi_HTDu1GkQZqPUqgyw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/59b208c03ab625710a229f805a232093"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ntla-begins-phase-iii-study-170700258.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4198","LU2362541513.USD","LU0106261612.USD","LU0053666078.USD","LU1169590202.USD","LU0109394709.USD","NTLA","BK4556","LU2468319806.SGD","LU2023250504.SGD","BK4134","LU1861559042.SGD","LU0289739699.SGD","ALNY","LU0823416689.USD","IE00B64QTZ34.USD","LU0205194284.USD","LU1861558580.USD","LU0320765992.SGD","LU2089984988.USD","REGN","HAE","LU1917777945.USD","LU0114720955.EUR","BK4535","ANIP","LU0012050646.USD","IE00BLDYK493.USD","LU1974910355.USD","LU0889565916.HKD","LU2362541273.HKD","BK4007","III","LU2362540622.SGD","LU2106854487.HKD","BK4588","BK4139","LU0205193047.USD","LU0882574055.USD","BK4585","LU0058720904.USD","LU1169589451.USD","BK4548"],"gpt_icon":0},{"id":"2474402962","title":"AstraZeneca Inks Agreement to Boost Cardiovascular Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2474402962","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474402962?lang=en_us&edition=fundamental","pubTime":"2024-10-09 01:05","pubTimestamp":1728407100,"startTime":"0","endTime":"0","summary":"AstraZeneca AZN announced that it has signed an exclusive license agreement with China-based CSPC Pharmaceutical Group Ltd for developing an early-stage, small molecule Lipoprotein   disruptor for helping patients with dyslipidaemia.The latest agreement is likely to strengthen AstraZeneca’s cardiovascular pipeline, which is being studied for treating various cardiovascular diseases.Year to date, shares of AstraZeneca have rallied 14.1% compared with the industry’s rise of 18.5%.Per the deal, AZN will make an upfront payment of $100 million to CSPC. The company is also entitled to pay up to $1.92 billion for further development and commercialization milestones plus tiered royalties to CSPC.Per the latest agreement with CSPC, AstraZeneca will gain access to the latter’s pre-clinical candidate, YS2302018, an oral Lp disruptor, and develop the same for various cardiovascular diseases. The company will develop YS2302018 alone or in combination studies, including with the oral small molecule","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/6pmiwRZRhtc7hxDNA3zxVQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ef77d5a5eb4e72e4dd31ccfaf4ca4ccd","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/6pmiwRZRhtc7hxDNA3zxVQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ef77d5a5eb4e72e4dd31ccfaf4ca4ccd"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/astrazeneca-inks-agreement-boost-cardiovascular-170500577.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4548","ALNY","LU1829250122.USD","LU0320765992.SGD","LU2417539215.USD","LDL","LU0889565916.HKD","ANIP","LU2456880835.USD","AZN","LU0109394709.USD","BK4139","BK4568","LU2236285917.USD","LU2462157665.USD","ADMA","BK4007","BK4588","BK4585","BK4082","CSII"],"gpt_icon":0},{"id":"2474403775","title":"SRRK Stock Soars as Muscle Disease Drug Meets Phase III Study Goal","url":"https://stock-news.laohu8.com/highlight/detail?id=2474403775","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474403775?lang=en_us&edition=fundamental","pubTime":"2024-10-08 22:56","pubTimestamp":1728399360,"startTime":"0","endTime":"0","summary":"Shares of Scholar RockSRRK skyrocketed 362% on Monday after the company announced positive top-line results from thelate-stage study, evaluating the efficacy and safety of its investigational muscle-targeted therapy, apitegromab, to treat spinal muscular atrophy .Apitegromab is a fully human monoclonal antibody inhibiting myostatin activation. Myostatin is a protein that is primarily produced in skeletal muscle cells and acts as a negative regulator of muscle growth. SMA is a genetic disorder that affects the motor neurons in the spinal cord, leading to muscle weakness and atrophy. Despite progress in developing treatments targeting motor neuron loss, there remains a significant unmet need for therapies that directly address the progressive muscle weakness responsible for the decline in motor function in SMA.Per the data readout, the phase III SAPPHIREstudy met its primary endpoint demonstrating a statistically significant and clinically meaningful improvement in motor function upon tr","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Z2Y2lgbJQfUa74IVYcsxPA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/41b7bdd28f63138df08f17b665d3589a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Z2Y2lgbJQfUa74IVYcsxPA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/41b7bdd28f63138df08f17b665d3589a"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/srrk-stock-soars-muscle-disease-145600682.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ANIP","LU1093756325.SGD","BK4134","SRRK","CPRX","LU1093756168.USD","BK4007","III","BHVN","BK4139"],"gpt_icon":0},{"id":"2473484688","title":"Johnson & Johnson Scraps Phase II Study on Antiviral for Dengue Virus","url":"https://stock-news.laohu8.com/highlight/detail?id=2473484688","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2473484688?lang=en_us&edition=fundamental","pubTime":"2024-10-08 00:59","pubTimestamp":1728320340,"startTime":"0","endTime":"0","summary":"Johnson & Johnson JNJ announced that it has discontinued the phase II field study, which evaluated the company’s investigational antiviral candidate mosnodenvir  for the prevention of dengue virus in patients aged between 18 years and 65 years.JNJ decided to stop this study  as part of the strategic reprioritization of its Communicable Diseases research and development (R&D) portfolio.Year to date, shares of JNJ have risen 2.3% compared with the industry’s growth of 18.5%.The phase II study evaluated the efficacy of mosnodenvir for preventing the dengue virus, a viral disease that spreads from mosquitoes to humans.Previously, mosnodenvir demonstrated safety and was well tolerated in phase I and phase IIa studies. Data from the phase IIa human challenge study showed that treatment with mosnodenvir induced antiviral activity against dengue  in humans versus placebo.Johnson & Johnson’s key areas of focus include immunology, infectious diseases & vaccines, neuroscience, cardiovascular & me","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/UjHemYIeF2aWxwD7gqDihg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/74bab520128f201c7e6cc3f67385e761","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/UjHemYIeF2aWxwD7gqDihg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/74bab520128f201c7e6cc3f67385e761"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/johnson-johnson-scraps-phase-ii-165900616.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B7SZLL34.SGD","LU0114720955.EUR","BK4550","IE00B19Z3581.USD","BK4007","BK4532","LU1074936037.SGD","LU1267930813.SGD","LU1244550221.USD","LU0795875169.SGD","LU0234572021.USD","LU0345769128.USD","LU1196500208.SGD","BK4504","IE00BVYPNV92.GBP","LU1059921491.USD","LU1032466523.USD","BK4559","BK4534","LU0345769631.USD","IE00BDGV0183.EUR","LU0203345920.USD","IE00BGHQF631.EUR","BVS","LU1244550494.USD","JNJ","LU0912757837.SGD","LU1430594728.SGD","LU1221951129.SGD","BK4581","IE00B3PB1722.GBP","LU0234570918.USD","LU0640476718.USD","LU0466842654.USD","LU1032955483.USD","BK4592","LU0345770993.USD","BK4588","LU1066053197.SGD","LU1244550577.SGD","ANIP","LU0889566641.SGD","LU0795875086.SGD","IE00BSNM7G36.USD","BK4533","IE00B42XCP33.USD","LU0345770308.USD","LU1162221912.USD","IE00BVYPNW00.USD","LU1221951046.USD"],"gpt_icon":0},{"id":"2473484691","title":"Sage Therapeutics Stock Down Almost 40% in 3 Months: Here's Why","url":"https://stock-news.laohu8.com/highlight/detail?id=2473484691","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2473484691?lang=en_us&edition=fundamental","pubTime":"2024-10-08 00:27","pubTimestamp":1728318420,"startTime":"0","endTime":"0","summary":"Sage Therapeutics, Inc. SAGE is focused on developing life-changing brain health medicines.In July, Sage Therapeutics and partner Biogen BIIB announced top-line data from the phase II KINETIC 2 study, which evaluated its investigational neurology candidate, SAGE-324 as a potential treatment for essential tremor . The study failed to demonstrate a statistically significant dose-response relationship on the primary endpoint in participants with ET.Following the disappointing data, SAGE and BIIB decided to stop further development of SAGE-324 for the ET indication.Last month, Biogen terminated its rights related to SAGE-324. The termination will be effective from Feb. 17, 2025.Following the termination of the deal by BIIB, Sage Therapeutics will obtain full ownership and rights of SAGE-324. The company plans to study SAGE-324 for other indications, if any.Shares of Sage Therapeutics have plunged 39.3% in the past three months against the industry’s growth of 7.9%.Sage Therapeutics has had","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/UtFJmA2Sogt3ia9UtBrVtA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/90c6165961c32b679207868449ac44ae","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/UtFJmA2Sogt3ia9UtBrVtA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/90c6165961c32b679207868449ac44ae"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sage-therapeutics-stock-down-almost-162700253.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ET","BK4007","BK4533","BK4139","BK4198","LU0109394709.USD","IE00B19Z9Z06.USD","BK4561","BK4590","LU0234570918.USD","BK4585","BK4581","ANIP","BIIB","PD","BK4588","IE00B894F039.SGD","LU0889565916.HKD","LU0390134368.USD","LU1169590202.USD","LU1169589451.USD","BK4023","IE00B19Z9P08.USD","BK4532","BVS","LU0320765992.SGD","BK4144","SAGE","BK4530","CRL","BK4121","PPD"],"gpt_icon":0},{"id":"2473489383","title":"ONCY Stock Up on Regulatory Update From Breast Cancer Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2473489383","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2473489383?lang=en_us&edition=fundamental","pubTime":"2024-10-07 23:47","pubTimestamp":1728316020,"startTime":"0","endTime":"0","summary":"Shares of Oncolytics Biotech ONCY rallied 18.2% on Friday after the company announced that it is seeking an accelerated pathway for the approval of its lead developmental candidate, pelareorep, for the metastatic breast cancer  indication. The stock is also gaining today.Pelareorep follows a unique mechanism of action, different from currently available therapeutics for this indication. It selectively targets cancer cells, triggering a cascade of inflammatory responses  that help the immune system eliminate the tumor while leaving healthy tissue unharmed.Recent Update From ONCY’s Breast Cancer Study of Pelareorep. Last month, Oncolytics reported positive data from its phase II BRACELET-1 study, which evaluated the combination regimen of pelareorep and standard-of-care chemotherapy  compared with paclitaxel monotherapy in patients with HR+/HER2-mBC.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/cYhdSHZ3kDYVQNhcMTsM_w--~B/aD0zOTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4a0e141116a5c1fff5e57140486a1890","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/cYhdSHZ3kDYVQNhcMTsM_w--~B/aD0zOTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4a0e141116a5c1fff5e57140486a1890"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/oncy-stock-regulatory-breast-cancer-154700214.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","03165","BK4568","BK4585","LU0320765992.SGD","LU1829250122.USD","LU2417539215.USD","BK4007","LU2236285917.USD","LU2456880835.USD","LU0109394709.USD","ONCY","BK4139","ANIP","LU0889565916.HKD","AZN","LU2462157665.USD","RHHBY"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":195}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ANIP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-28","symbol":"ANIP","fiscalQuarterEnding":"2024/12","expectedEps":1.14,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740718800000,"reportTimeType":"pre","actualEps":1.35},{"market":"US","date":"2025-01-13","symbol":"ANIP","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1736744400000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2024-11-08","symbol":"ANIP","fiscalQuarterEnding":"2024/09","expectedEps":0.76,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731042000000,"reportTimeType":"pre","actualEps":1.04},{"market":"US","date":"2024-08-06","symbol":"ANIP","fiscalQuarterEnding":"2024/06","expectedEps":0.64,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1722916800000,"reportTimeType":"pre","actualEps":0.72},{"market":"US","date":"2024-05-10","symbol":"ANIP","fiscalQuarterEnding":"2024/03","expectedEps":0.79,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715313600000,"reportTimeType":"pre","actualEps":0.95}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ANIP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ANIP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.375,"buy":0.5,"hold":0.125,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":8,"updateTime":1742011200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ANIP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ANIP","date":"2025-04-04","current":-74.873618,"percent":0.161501,"low":-311.184856,"twenty":-37.127584,"median":-15.916284,"eighty":33.489434,"high":97.86975,"avg":-34.4095,"sd":88.145289,"marketCap":1386809145},"quantilePoints":[{"date":"2020-04-09","current":92.224169,"twenty":21.531406,"median":49.390116,"eighty":175.320971,"marketCap":562014088},{"date":"2020-04-17","current":84.253938,"twenty":21.569236,"median":49.501086,"eighty":175.341115,"marketCap":513443500},{"date":"2020-04-24","current":84.512513,"twenty":21.639216,"median":49.740542,"eighty":175.341115,"marketCap":515019254},{"date":"2020-05-01","current":78.483131,"twenty":21.68665,"median":49.897003,"eighty":175.341115,"marketCap":478276200},{"date":"2020-05-08","current":-306.724064,"twenty":21.68665,"median":49.897003,"eighty":174.662929,"marketCap":418985071},{"date":"2020-05-15","current":-276.747541,"twenty":21.639216,"median":49.740542,"eighty":171.157853,"marketCap":378037141},{"date":"2020-05-22","current":-281.654412,"twenty":21.569236,"median":49.501086,"eighty":129.970868,"marketCap":384739927},{"date":"2020-05-29","current":-277.104405,"twenty":21.540251,"median":49.4105,"eighty":114.118791,"marketCap":378524617},{"date":"2020-06-05","current":-287.007363,"twenty":21.490641,"median":49.320114,"eighty":112.769329,"marketCap":392052058},{"date":"2020-06-12","current":-279.334801,"twenty":21.43174,"median":49.19183,"eighty":110.88517,"marketCap":381571338},{"date":"2020-06-19","current":-267.023015,"twenty":21.397336,"median":49.143393,"eighty":110.230911,"marketCap":364753438},{"date":"2020-06-26","current":-271.84067,"twenty":21.260922,"median":48.961869,"eighty":109.609404,"marketCap":371334355},{"date":"2020-07-02","current":-275.587735,"twenty":21.213916,"median":48.819209,"eighty":108.674596,"marketCap":376452846},{"date":"2020-07-10","current":-242.656217,"twenty":21.146728,"median":48.595145,"eighty":107.483212,"marketCap":331468393},{"date":"2020-07-17","current":-267.608014,"twenty":21.004704,"median":48.464447,"eighty":106.487144,"marketCap":365552547},{"date":"2020-07-24","current":-236.240042,"twenty":20.955588,"median":48.183479,"eighty":105.494518,"marketCap":322703897},{"date":"2020-07-31","current":-263.865245,"twenty":20.91187,"median":47.740116,"eighty":104.82867,"marketCap":360439924},{"date":"2020-08-07","current":-17.948035,"twenty":20.772397,"median":47.399928,"eighty":102.855769,"marketCap":364111791},{"date":"2020-08-14","current":-19.147723,"twenty":20.710873,"median":47.109625,"eighty":102.014304,"marketCap":388449853},{"date":"2020-08-21","current":-18.462187,"twenty":20.602327,"median":46.853471,"eighty":100.138989,"marketCap":374542389},{"date":"2020-08-28","current":-18.474007,"twenty":20.558652,"median":46.566876,"eighty":99.313001,"marketCap":374782173},{"date":"2020-09-04","current":-17.227041,"twenty":20.458555,"median":46.389314,"eighty":97.780868,"marketCap":349484975},{"date":"2020-09-11","current":-16.322843,"twenty":20.389015,"median":46.259964,"eighty":95.080791,"marketCap":331141510},{"date":"2020-09-18","current":-17.942125,"twenty":20.307358,"median":45.914271,"eighty":94.158771,"marketCap":363991899},{"date":"2020-09-25","current":-16.10418,"twenty":20.231122,"median":45.803098,"eighty":93.899855,"marketCap":326705509},{"date":"2020-10-02","current":-16.896092,"twenty":20.188569,"median":45.677543,"eighty":93.899855,"marketCap":342771027},{"date":"2020-10-09","current":-18.190337,"twenty":20.1016,"median":45.515812,"eighty":93.831974,"marketCap":369027360},{"date":"2020-10-16","current":-17.605267,"twenty":20.025882,"median":45.358477,"eighty":93.831974,"marketCap":357158059},{"date":"2020-10-23","current":-17.108845,"twenty":19.935944,"median":45.290838,"eighty":93.831974,"marketCap":347087137},{"date":"2020-10-30","current":-15.064057,"twenty":19.853111,"median":45.178762,"eighty":93.831974,"marketCap":305604529},{"date":"2020-11-06","current":-11.966257,"twenty":19.635625,"median":45.101076,"eighty":93.831974,"marketCap":284174674},{"date":"2020-11-13","current":-14.042294,"twenty":19.43091,"median":45.101076,"eighty":93.831974,"marketCap":333476401},{"date":"2020-11-20","current":-14.15342,"twenty":19.270511,"median":45.101076,"eighty":93.831974,"marketCap":336115423},{"date":"2020-11-27","current":-14.890893,"twenty":19.083542,"median":45.101076,"eighty":93.831974,"marketCap":353628931},{"date":"2020-12-04","current":-14.815125,"twenty":18.677139,"median":45.033423,"eighty":93.831974,"marketCap":351829598},{"date":"2020-12-11","current":-15.118197,"twenty":18.135705,"median":44.963168,"eighty":93.831974,"marketCap":359026931},{"date":"2020-12-18","current":-15.744543,"twenty":17.809673,"median":44.893709,"eighty":93.831974,"marketCap":373901418},{"date":"2020-12-24","current":-14.143318,"twenty":17.67856,"median":44.788392,"eighty":93.831974,"marketCap":335875512},{"date":"2020-12-31","current":-14.668641,"twenty":17.562123,"median":44.750872,"eighty":93.831974,"marketCap":348350888},{"date":"2021-01-08","current":-15.81526,"twenty":17.494531,"median":44.671419,"eighty":93.831974,"marketCap":375580795},{"date":"2021-01-15","current":-16.229457,"twenty":17.372674,"median":44.671419,"eighty":93.831974,"marketCap":385417150},{"date":"2021-01-22","current":-16.209252,"twenty":17.122322,"median":44.671419,"eighty":93.831974,"marketCap":384937327},{"date":"2021-01-29","current":-14.416082,"twenty":16.943136,"median":44.671419,"eighty":93.831974,"marketCap":342353111},{"date":"2021-02-05","current":-15.512189,"twenty":16.763257,"median":44.671419,"eighty":93.831974,"marketCap":368383463},{"date":"2021-02-12","current":-15.906181,"twenty":16.268593,"median":44.671419,"eighty":93.831974,"marketCap":377739995},{"date":"2021-02-19","current":-15.274783,"twenty":15.830659,"median":44.671419,"eighty":93.831974,"marketCap":362745552},{"date":"2021-02-26","current":-14.698948,"twenty":-12.119813,"median":44.671419,"eighty":93.831974,"marketCap":349070621},{"date":"2021-03-05","current":-14.900996,"twenty":-13.866513,"median":44.684665,"eighty":93.840828,"marketCap":353868843},{"date":"2021-03-12","current":-17.719586,"twenty":-14.185748,"median":44.684665,"eighty":93.840828,"marketCap":399541231},{"date":"2021-03-19","current":-18.809938,"twenty":-14.28172,"median":44.684665,"eighty":93.840828,"marketCap":424126483},{"date":"2021-03-26","current":-17.905878,"twenty":-14.478717,"median":44.671419,"eighty":93.831974,"marketCap":403741726},{"date":"2021-04-01","current":-18.645563,"twenty":-14.700969,"median":44.671419,"eighty":93.831974,"marketCap":420420163},{"date":"2021-04-09","current":-17.456587,"twenty":-14.79391,"median":44.684665,"eighty":93.840828,"marketCap":393611120},{"date":"2021-04-16","current":-18.727751,"twenty":-14.933323,"median":44.684665,"eighty":93.840828,"marketCap":422273323},{"date":"2021-04-23","current":-18.490979,"twenty":-15.018183,"median":44.619273,"eighty":93.840828,"marketCap":416934604},{"date":"2021-04-30","current":-18.67617,"twenty":-15.151534,"median":44.517552,"eighty":93.840828,"marketCap":421110277},{"date":"2021-05-07","current":-30.006302,"twenty":-15.294988,"median":44.482394,"eighty":93.840828,"marketCap":463627379},{"date":"2021-05-14","current":-27.254429,"twenty":-15.522291,"median":44.482394,"eighty":93.840828,"marketCap":421108184},{"date":"2021-05-21","current":-27.503186,"twenty":-15.637458,"median":44.482394,"eighty":93.840828,"marketCap":424951727},{"date":"2021-05-28","current":-26.7025,"twenty":-15.830414,"median":44.482394,"eighty":93.840828,"marketCap":412580323},{"date":"2021-06-04","current":-26.725821,"twenty":-15.90012,"median":44.482394,"eighty":93.840828,"marketCap":412940655},{"date":"2021-06-11","current":-27.091182,"twenty":-16.033471,"median":44.482394,"eighty":93.840828,"marketCap":418585859},{"date":"2021-06-18","current":-25.629735,"twenty":-16.113636,"median":44.482394,"eighty":93.840828,"marketCap":396005043},{"date":"2021-06-25","current":-25.684151,"twenty":-16.211273,"median":44.482394,"eighty":93.840828,"marketCap":396845818},{"date":"2021-07-02","current":-27.238882,"twenty":-16.280292,"median":44.482394,"eighty":93.840828,"marketCap":420867962},{"date":"2021-07-09","current":-25.917361,"twenty":-16.381941,"median":44.482394,"eighty":93.840828,"marketCap":400449140},{"date":"2021-07-16","current":-25.458715,"twenty":-16.61715,"median":44.482394,"eighty":93.840828,"marketCap":393362608},{"date":"2021-07-23","current":-25.754114,"twenty":-16.70107,"median":44.482394,"eighty":93.840828,"marketCap":397926815},{"date":"2021-07-30","current":-26.376006,"twenty":-16.867725,"median":44.482394,"eighty":93.840828,"marketCap":407535672},{"date":"2021-08-06","current":-23.241466,"twenty":-17.134848,"median":44.482394,"eighty":93.840828,"marketCap":400241286},{"date":"2021-08-13","current":-21.12541,"twenty":-17.212103,"median":44.482394,"eighty":93.840828,"marketCap":363800685},{"date":"2021-08-20","current":-19.656122,"twenty":-17.353092,"median":44.482394,"eighty":93.840828,"marketCap":338498075},{"date":"2021-08-27","current":-19.656122,"twenty":-17.522336,"median":44.482394,"eighty":93.840828,"marketCap":338498075},{"date":"2021-09-03","current":-20.738755,"twenty":-17.700637,"median":44.482394,"eighty":93.840828,"marketCap":357142104},{"date":"2021-09-10","current":-19.290557,"twenty":-17.899303,"median":44.482394,"eighty":93.840828,"marketCap":332202689},{"date":"2021-09-17","current":-20.30992,"twenty":-18.060321,"median":44.482394,"eighty":93.840828,"marketCap":349757131},{"date":"2021-09-24","current":-22.461126,"twenty":-18.091073,"median":44.482394,"eighty":93.840828,"marketCap":386803058},{"date":"2021-10-01","current":-23.60703,"twenty":-18.425232,"median":44.482394,"eighty":93.840828,"marketCap":406536672},{"date":"2021-10-08","current":-26.123801,"twenty":-18.468453,"median":44.482394,"eighty":93.840828,"marketCap":449877985},{"date":"2021-10-15","current":-27.093953,"twenty":-18.504447,"median":44.482394,"eighty":93.840828,"marketCap":466584972},{"date":"2021-10-22","current":-25.912899,"twenty":-18.647858,"median":44.482394,"eighty":93.840828,"marketCap":446246032},{"date":"2021-10-29","current":-26.278463,"twenty":-18.720372,"median":44.482394,"eighty":93.840828,"marketCap":452541418},{"date":"2021-11-05","current":-27.374652,"twenty":-18.921969,"median":44.482394,"eighty":93.840828,"marketCap":605034567},{"date":"2021-11-12","current":-24.93381,"twenty":-19.161127,"median":44.482394,"eighty":93.840828,"marketCap":551087062},{"date":"2021-11-19","current":-23.828316,"twenty":-19.298993,"median":44.482394,"eighty":93.840828,"marketCap":526653439},{"date":"2021-11-26","current":-22.312367,"twenty":-19.550771,"median":44.482394,"eighty":93.840828,"marketCap":493147926},{"date":"2021-12-03","current":-21.644692,"twenty":-19.661746,"median":44.482394,"eighty":93.840828,"marketCap":478390986},{"date":"2021-12-10","current":-23.926825,"twenty":-19.830468,"median":44.482394,"eighty":93.840828,"marketCap":528830693},{"date":"2021-12-17","current":-35.479789,"twenty":-20.340852,"median":44.482394,"eighty":93.840828,"marketCap":784174295},{"date":"2021-12-23","current":-38.555108,"twenty":-20.692356,"median":44.482394,"eighty":93.840828,"marketCap":852144996},{"date":"2021-12-31","current":-34.904113,"twenty":-21.292726,"median":44.482394,"eighty":93.840828,"marketCap":771450716},{"date":"2022-01-07","current":-33.23011,"twenty":-21.571117,"median":44.47091,"eighty":93.831974,"marketCap":734451886},{"date":"2022-01-14","current":-32.593837,"twenty":-22.321029,"median":44.47091,"eighty":93.831974,"marketCap":720388982},{"date":"2022-01-21","current":-31.056177,"twenty":-22.471872,"median":44.47091,"eighty":93.831974,"marketCap":686403632},{"date":"2022-01-28","current":-29.81393,"twenty":-23.061496,"median":44.47091,"eighty":93.831974,"marketCap":658947486},{"date":"2022-02-04","current":-29.064037,"twenty":-23.582662,"median":44.47091,"eighty":93.831974,"marketCap":642373350},{"date":"2022-02-11","current":-29.783632,"twenty":-23.857812,"median":44.47091,"eighty":93.831974,"marketCap":658277824},{"date":"2022-02-18","current":-28.336868,"twenty":-24.385441,"median":44.47091,"eighty":93.831974,"marketCap":626301460},{"date":"2022-02-25","current":-28.382316,"twenty":-24.728034,"median":44.47091,"eighty":93.831974,"marketCap":627305953},{"date":"2022-03-04","current":-27.473355,"twenty":-25.399635,"median":44.47091,"eighty":93.831974,"marketCap":607216091},{"date":"2022-03-11","current":-27.503654,"twenty":-25.579458,"median":44.47091,"eighty":93.831974,"marketCap":607885753},{"date":"2022-03-18","current":-10.584628,"twenty":-25.602756,"median":44.47091,"eighty":93.831974,"marketCap":450936898},{"date":"2022-03-25","current":-11.332448,"twenty":-25.602756,"median":44.47091,"eighty":93.831974,"marketCap":482796267},{"date":"2022-04-01","current":-11.620114,"twenty":-25.602756,"median":44.47091,"eighty":93.831974,"marketCap":495051732},{"date":"2022-04-08","current":-12.118467,"twenty":-25.602756,"median":44.47091,"eighty":93.831974,"marketCap":516283030},{"date":"2022-04-14","current":-13.030086,"twenty":-25.602756,"median":44.47091,"eighty":93.831974,"marketCap":555120770},{"date":"2022-04-22","current":-13.082758,"twenty":-25.602756,"median":44.47091,"eighty":93.831974,"marketCap":557364729},{"date":"2022-04-29","current":-11.956401,"twenty":-25.602756,"median":44.47091,"eighty":93.831974,"marketCap":509378543},{"date":"2022-05-06","current":-11.109607,"twenty":-25.602756,"median":44.423407,"eighty":93.831974,"marketCap":473302597},{"date":"2022-05-13","current":-6.838809,"twenty":-25.602756,"median":44.326499,"eighty":93.831974,"marketCap":429607173},{"date":"2022-05-20","current":-7.973013,"twenty":-25.602756,"median":44.264099,"eighty":93.831974,"marketCap":500856719},{"date":"2022-05-27","current":-8.009184,"twenty":-25.602756,"median":44.233827,"eighty":93.831974,"marketCap":503128915},{"date":"2022-06-03","current":-7.554469,"twenty":-25.602756,"median":44.233827,"eighty":93.831974,"marketCap":474564176},{"date":"2022-06-10","current":-7.099754,"twenty":-25.602756,"median":44.233827,"eighty":93.831974,"marketCap":445999438},{"date":"2022-06-17","current":-6.298835,"twenty":-25.602756,"median":44.233827,"eighty":93.831974,"marketCap":395686546},{"date":"2022-06-24","current":-7.46921,"twenty":-25.609501,"median":44.218628,"eighty":93.840828,"marketCap":469208288},{"date":"2022-07-01","current":-8.147407,"twenty":-25.609501,"median":44.029158,"eighty":93.840828,"marketCap":511811946},{"date":"2022-07-08","current":-8.125446,"twenty":-25.609501,"median":43.718314,"eighty":93.840828,"marketCap":510432399},{"date":"2022-07-15","current":-8.09961,"twenty":-25.609501,"median":43.551201,"eighty":93.840828,"marketCap":508809402},{"date":"2022-07-22","current":-8.202954,"twenty":-25.609501,"median":43.064392,"eighty":93.840828,"marketCap":515301388},{"date":"2022-07-29","current":-8.848856,"twenty":-25.609501,"median":42.112572,"eighty":93.840828,"marketCap":555876301},{"date":"2022-08-05","current":-8.94445,"twenty":-25.609501,"median":41.698422,"eighty":93.840828,"marketCap":561881388},{"date":"2022-08-12","current":-9.587738,"twenty":-25.609501,"median":41.211613,"eighty":93.840828,"marketCap":610125283},{"date":"2022-08-19","current":-9.160422,"twenty":-25.609501,"median":40.434173,"eighty":93.840828,"marketCap":582932617},{"date":"2022-08-26","current":-9.723353,"twenty":-25.609501,"median":-6.017222,"eighty":93.840828,"marketCap":618755292},{"date":"2022-09-02","current":-9.357448,"twenty":-25.609501,"median":-6.461603,"eighty":93.840828,"marketCap":595470553},{"date":"2022-09-09","current":-9.490504,"twenty":-25.609501,"median":-6.838809,"eighty":93.840828,"marketCap":603937731},{"date":"2022-09-16","current":-9.160422,"twenty":-25.609501,"median":-7.340029,"eighty":93.840828,"marketCap":582932617},{"date":"2022-09-23","current":-8.113882,"twenty":-25.609501,"median":-7.46921,"eighty":93.840828,"marketCap":516335008},{"date":"2022-09-30","current":-8.22391,"twenty":-25.609501,"median":-7.665564,"eighty":93.840828,"marketCap":523336712},{"date":"2022-10-07","current":-8.254615,"twenty":-25.609501,"median":-7.797328,"eighty":93.840828,"marketCap":525290676},{"date":"2022-10-14","current":-8.500258,"twenty":-25.609501,"median":-7.91359,"eighty":93.840828,"marketCap":540922389},{"date":"2022-10-21","current":-9.242303,"twenty":-25.609501,"median":-8.0066,"eighty":93.840828,"marketCap":588143188},{"date":"2022-10-28","current":-9.961319,"twenty":-25.609501,"median":-8.102194,"eighty":93.840828,"marketCap":633898513},{"date":"2022-11-04","current":-9.810351,"twenty":-25.609501,"median":-8.182285,"eighty":93.840828,"marketCap":624291523},{"date":"2022-11-11","current":-9.043105,"twenty":-25.609501,"median":-8.22391,"eighty":93.840828,"marketCap":613023068},{"date":"2022-11-18","current":-9.514501,"twenty":-25.609501,"median":-8.355252,"eighty":93.72897,"marketCap":644978525},{"date":"2022-11-25","current":-10.019568,"twenty":-25.609501,"median":-8.433729,"eighty":93.149414,"marketCap":679216516},{"date":"2022-12-02","current":-9.33893,"twenty":-25.609501,"median":-8.569345,"eighty":92.137422,"marketCap":633076748},{"date":"2022-12-09","current":-9.500071,"twenty":-25.609501,"median":-8.699842,"eighty":91.159402,"marketCap":644000297},{"date":"2022-12-16","current":-9.156144,"twenty":-25.609501,"median":-8.830771,"eighty":90.084372,"marketCap":620685856},{"date":"2022-12-23","current":-9.488045,"twenty":-25.609501,"median":-8.885027,"eighty":88.207549,"marketCap":643185107},{"date":"2022-12-30","current":-9.675642,"twenty":-25.609501,"median":-8.94445,"eighty":85.476822,"marketCap":655902075},{"date":"2023-01-06","current":-10.563117,"twenty":-25.609501,"median":-9.037601,"eighty":84.678021,"marketCap":716063115},{"date":"2023-01-13","current":-10.570332,"twenty":-25.609501,"median":-9.055512,"eighty":83.785101,"marketCap":716552229},{"date":"2023-01-20","current":-10.106151,"twenty":-25.609501,"median":-9.156144,"eighty":81.714404,"marketCap":685085886},{"date":"2023-01-27","current":-10.488559,"twenty":-25.609501,"median":-9.178333,"eighty":79.307707,"marketCap":711008936},{"date":"2023-02-03","current":-10.743498,"twenty":-25.609501,"median":-9.319066,"eighty":78.151242,"marketCap":728290969},{"date":"2023-02-10","current":-10.822865,"twenty":-25.609501,"median":-9.34374,"eighty":74.795751,"marketCap":733671225},{"date":"2023-02-17","current":-10.36109,"twenty":-25.609501,"median":-9.437539,"eighty":73.316501,"marketCap":702367919},{"date":"2023-02-24","current":-9.892099,"twenty":-25.609501,"median":-9.463995,"eighty":72.702367,"marketCap":670575499},{"date":"2023-03-03","current":-10.933499,"twenty":-25.435394,"median":-9.467475,"eighty":72.512607,"marketCap":741170975},{"date":"2023-03-10","current":-13.950056,"twenty":-24.971129,"median":-9.467475,"eighty":72.512607,"marketCap":668151872},{"date":"2023-03-17","current":-13.434525,"twenty":-24.508031,"median":-9.467475,"eighty":72.512607,"marketCap":643460014},{"date":"2023-03-24","current":-12.84047,"twenty":-23.901482,"median":-9.467475,"eighty":72.512607,"marketCap":615007144},{"date":"2023-03-31","current":-13.560847,"twenty":-23.734185,"median":-9.47776,"eighty":72.457404,"marketCap":649510337},{"date":"2023-04-06","current":-13.103356,"twenty":-23.276616,"median":-9.47776,"eighty":72.457404,"marketCap":627598357},{"date":"2023-04-14","current":-14.566675,"twenty":-22.927503,"median":-9.467475,"eighty":72.512607,"marketCap":697685448},{"date":"2023-04-21","current":-14.813567,"twenty":-22.372547,"median":-9.467475,"eighty":72.512607,"marketCap":709510626},{"date":"2023-04-28","current":-13.949443,"twenty":-21.607296,"median":-9.467475,"eighty":72.512607,"marketCap":668122506},{"date":"2023-05-05","current":-14.230003,"twenty":-21.372869,"median":-9.467475,"eighty":72.512607,"marketCap":681560207},{"date":"2023-05-11","current":-29.794637,"twenty":-21.500816,"median":-9.500071,"eighty":72.007154,"marketCap":784403414},{"date":"2023-05-19","current":-56.777451,"twenty":-22.064999,"median":-9.532539,"eighty":71.204986,"marketCap":1494779963},{"date":"2023-05-26","current":-32.844617,"twenty":-22.451972,"median":-9.621527,"eighty":70.195747,"marketCap":864700227},{"date":"2023-06-02","current":-33.036774,"twenty":-22.980041,"median":-9.652793,"eighty":69.862862,"marketCap":869759145},{"date":"2023-06-09","current":-35.484997,"twenty":-23.178195,"median":-9.670148,"eighty":68.90026,"marketCap":934213507},{"date":"2023-06-16","current":-36.089935,"twenty":-23.724334,"median":-9.72975,"eighty":67.226918,"marketCap":950139730},{"date":"2023-06-23","current":-36.68064,"twenty":-23.894858,"median":-9.77906,"eighty":63.86816,"marketCap":965691218},{"date":"2023-06-30","current":-38.082675,"twenty":-24.395292,"median":-9.853618,"eighty":61.559985,"marketCap":1002602582},{"date":"2023-07-07","current":-38.075558,"twenty":-24.746642,"median":-9.912543,"eighty":60.9286,"marketCap":1002415215},{"date":"2023-07-14","current":-35.976065,"twenty":-25.402745,"median":-10.017163,"eighty":60.493876,"marketCap":947141853},{"date":"2023-07-21","current":-36.780277,"twenty":-25.583596,"median":-10.097734,"eighty":60.038451,"marketCap":968314361},{"date":"2023-07-28","current":-36.68064,"twenty":-25.679487,"median":-10.317799,"eighty":59.150503,"marketCap":965691218},{"date":"2023-08-04","current":-37.136124,"twenty":-25.757224,"median":-10.457372,"eighty":56.817084,"marketCap":977682727},{"date":"2023-08-11","current":-222.079037,"twenty":-25.850737,"median":-10.495794,"eighty":54.293227,"marketCap":1145705754},{"date":"2023-08-18","current":-219.587884,"twenty":-25.917361,"median":-10.583761,"eighty":54.037177,"marketCap":1132853892},{"date":"2023-08-25","current":-232.080287,"twenty":-26.074388,"median":-10.682168,"eighty":53.63505,"marketCap":1197302203},{"date":"2023-09-01","current":-235.890287,"twenty":-26.135023,"median":-10.804827,"eighty":53.39322,"marketCap":1216957993},{"date":"2023-09-08","current":-229.662403,"twenty":-26.198767,"median":-10.842106,"eighty":53.156773,"marketCap":1184828336},{"date":"2023-09-15","current":-233.032787,"twenty":-26.325403,"median":-10.964765,"eighty":53.067365,"marketCap":1202216150},{"date":"2023-09-22","current":-217.353172,"twenty":-26.546851,"median":-11.360809,"eighty":52.793727,"marketCap":1121325015},{"date":"2023-09-29","current":-215.741249,"twenty":-26.616774,"median":-11.672785,"eighty":52.273601,"marketCap":1113009104},{"date":"2023-10-06","current":-214.788749,"twenty":-26.733499,"median":-11.954375,"eighty":50.934555,"marketCap":1108095156},{"date":"2023-10-13","current":-212.260961,"twenty":-27.062768,"median":-12.073899,"eighty":50.197317,"marketCap":1095054296},{"date":"2023-10-20","current":-209.95298,"twenty":-27.148708,"median":-12.393978,"eighty":49.856152,"marketCap":1083147423},{"date":"2023-10-27","current":-221.566153,"twenty":-27.192662,"median":-12.734037,"eighty":49.51106,"marketCap":1143059783},{"date":"2023-11-03","current":-229.186153,"twenty":-27.249765,"median":-13.028246,"eighty":49.395552,"marketCap":1182371362},{"date":"2023-11-10","current":74.513877,"twenty":-27.312133,"median":-13.082758,"eighty":49.346018,"marketCap":997070186},{"date":"2023-11-17","current":73.087774,"twenty":-27.312133,"median":-13.082758,"eighty":49.346018,"marketCap":977987503},{"date":"2023-11-24","current":73.943436,"twenty":-27.312133,"median":-13.082758,"eighty":49.346018,"marketCap":989437113},{"date":"2023-12-01","current":71.034186,"twenty":-27.312133,"median":-13.082758,"eighty":49.346018,"marketCap":950508440},{"date":"2023-12-08","current":69.493995,"twenty":-27.294941,"median":-13.056422,"eighty":49.358996,"marketCap":929899142},{"date":"2023-12-15","current":75.440844,"twenty":-27.312133,"median":-13.082758,"eighty":49.346018,"marketCap":1009473930},{"date":"2023-12-22","current":75.768847,"twenty":-27.312133,"median":-13.082758,"eighty":49.346018,"marketCap":1013862947},{"date":"2023-12-29","current":78.178961,"twenty":-27.329324,"median":-13.093057,"eighty":49.324601,"marketCap":1046112682},{"date":"2024-01-05","current":80.047156,"twenty":-27.346516,"median":-13.103356,"eighty":49.293085,"marketCap":1071110996},{"date":"2024-01-12","current":79.562281,"twenty":-27.346516,"median":-13.103356,"eighty":49.293085,"marketCap":1064622884},{"date":"2024-01-19","current":79.277061,"twenty":-27.363707,"median":-13.103356,"eighty":49.274727,"marketCap":1060806347},{"date":"2024-01-26","current":77.437388,"twenty":-27.346516,"median":-13.103356,"eighty":49.293085,"marketCap":1036189686},{"date":"2024-02-02","current":80.589075,"twenty":-27.346516,"median":-13.103356,"eighty":49.293085,"marketCap":1078362416},{"date":"2024-02-09","current":79.733413,"twenty":-27.346516,"median":-13.103356,"eighty":49.293085,"marketCap":1066912806},{"date":"2024-02-16","current":82.072222,"twenty":-27.346516,"median":-13.103356,"eighty":49.293085,"marketCap":1098208406},{"date":"2024-02-23","current":82.927884,"twenty":-27.346516,"median":-13.103356,"eighty":49.293085,"marketCap":1109658016},{"date":"2024-03-01","current":71.050516,"twenty":-27.329324,"median":-13.093057,"eighty":49.324601,"marketCap":1334257645},{"date":"2024-03-08","current":70.042559,"twenty":-27.329324,"median":-13.093057,"eighty":49.411858,"marketCap":1315329208},{"date":"2024-03-15","current":69.349588,"twenty":-27.329324,"median":-13.093057,"eighty":49.604826,"marketCap":1302315908},{"date":"2024-03-22","current":72.782944,"twenty":-27.329324,"median":-13.093057,"eighty":49.993478,"marketCap":1366790897},{"date":"2024-03-28","current":73.171427,"twenty":-27.329324,"median":-13.093057,"eighty":49.993478,"marketCap":1374086232},{"date":"2024-04-05","current":71.334004,"twenty":-27.346516,"median":-13.103356,"eighty":49.894276,"marketCap":1339581268},{"date":"2024-04-12","current":76.093972,"twenty":-27.346516,"median":-13.103356,"eighty":49.894276,"marketCap":1428968709},{"date":"2024-04-19","current":72.15018,"twenty":-27.346516,"median":-13.103356,"eighty":49.894276,"marketCap":1354908226},{"date":"2024-04-26","current":72.563552,"twenty":-27.329324,"median":-13.093057,"eighty":49.993478,"marketCap":1362670939},{"date":"2024-05-03","current":74.976751,"twenty":-27.329324,"median":-13.093057,"eighty":49.993478,"marketCap":1407988402},{"date":"2024-05-10","current":73.602568,"twenty":-27.329324,"median":-13.093057,"eighty":49.993478,"marketCap":1382182625},{"date":"2024-05-17","current":34.818397,"twenty":-27.329324,"median":-13.093057,"eighty":49.604826,"marketCap":1237689546},{"date":"2024-05-24","current":32.956538,"twenty":-27.329324,"median":-13.093057,"eighty":49.398269,"marketCap":1171506053},{"date":"2024-05-31","current":34.649137,"twenty":-27.329324,"median":-13.093057,"eighty":49.201225,"marketCap":1231672865},{"date":"2024-06-07","current":37.575695,"twenty":-27.329324,"median":-13.093057,"eighty":49.058538,"marketCap":1335703224},{"date":"2024-06-14","current":34.529017,"twenty":-27.346516,"median":-13.103356,"eighty":48.618246,"marketCap":1227402962},{"date":"2024-06-21","current":32.426918,"twenty":-27.363707,"median":-13.103356,"eighty":48.282592,"marketCap":1152679664},{"date":"2024-06-28","current":34.447117,"twenty":-27.368103,"median":-13.144326,"eighty":47.697066,"marketCap":1224491665},{"date":"2024-07-05","current":33.207698,"twenty":-27.368103,"median":-13.144326,"eighty":47.191366,"marketCap":1180434032},{"date":"2024-07-12","current":35.080476,"twenty":-27.368103,"median":-13.144326,"eighty":46.545561,"marketCap":1247005698},{"date":"2024-07-15","current":34.670977,"twenty":-27.368103,"median":-13.144326,"eighty":46.458973,"marketCap":1232449211},{"date":"2024-08-02","current":34.862077,"twenty":-27.415745,"median":-13.397035,"eighty":45.466555,"marketCap":1239242238},{"date":"2024-08-09","current":40.770114,"twenty":-27.415745,"median":-13.397035,"eighty":45.054829,"marketCap":1101404633},{"date":"2024-08-16","current":44.144143,"twenty":-27.415745,"median":-13.397035,"eighty":44.802371,"marketCap":1192554015},{"date":"2024-08-23","current":43.725098,"twenty":-27.415745,"median":-13.397035,"eighty":44.635258,"marketCap":1181233535},{"date":"2024-08-30","current":45.119504,"twenty":-27.415745,"median":-13.397035,"eighty":44.702103,"marketCap":1218903409},{"date":"2024-09-06","current":43.898496,"twenty":-27.415745,"median":-13.397035,"eighty":44.847419,"marketCap":1185917872},{"date":"2024-09-13","current":40.567817,"twenty":-27.415745,"median":-13.397035,"eighty":44.64979,"marketCap":1095939574},{"date":"2024-09-20","current":43.62395,"twenty":-27.415745,"median":-13.397035,"eighty":44.561555,"marketCap":1178501006},{"date":"2024-09-27","current":42.121171,"twenty":-27.415745,"median":-13.397035,"eighty":44.436175,"marketCap":1137903422},{"date":"2024-10-04","current":41.030211,"twenty":-27.415745,"median":-13.397035,"eighty":44.244358,"marketCap":1108431138},{"date":"2024-10-11","current":39.809202,"twenty":-27.415745,"median":-13.397035,"eighty":44.115243,"marketCap":1075445601},{"date":"2024-10-18","current":43.436102,"twenty":-27.415745,"median":-13.397035,"eighty":43.717962,"marketCap":1173426308},{"date":"2024-10-25","current":42.829211,"twenty":-27.415745,"median":-13.397035,"eighty":43.625385,"marketCap":1157031130},{"date":"2024-10-31","current":42.272893,"twenty":-27.415745,"median":-13.397035,"eighty":43.412983,"marketCap":1142002217},{"date":"2024-11-08","current":42.17897,"twenty":-27.424001,"median":-13.427697,"eighty":43.200989,"marketCap":1139464868},{"date":"2024-11-15","current":-162.206247,"twenty":-27.58243,"median":-13.5568,"eighty":43.200989,"marketCap":1150204495},{"date":"2024-11-22","current":-153.808198,"twenty":-27.970377,"median":-13.659856,"eighty":43.200989,"marketCap":1090653931},{"date":"2024-11-29","current":-157.580436,"twenty":-28.373227,"median":-13.949443,"eighty":43.137369,"marketCap":1117402873},{"date":"2024-12-06","current":-154.166148,"twenty":-28.925081,"median":-14.069148,"eighty":43.103757,"marketCap":1093192152},{"date":"2024-12-13","current":-155.735619,"twenty":-29.536697,"median":-14.163523,"eighty":42.711788,"marketCap":1104321274},{"date":"2024-12-20","current":-149.402664,"twenty":-29.809386,"median":-14.230003,"eighty":42.389937,"marketCap":1059414291},{"date":"2024-12-27","current":-152.816953,"twenty":-30.032369,"median":-14.259929,"eighty":42.268559,"marketCap":1083625012},{"date":"2025-01-03","current":-152.651745,"twenty":-30.59903,"median":-14.334745,"eighty":42.15296,"marketCap":1082453526},{"date":"2025-01-10","current":-149.127318,"twenty":-31.037127,"median":-14.458652,"eighty":42.12984,"marketCap":1057461814},{"date":"2025-01-17","current":-158.32387,"twenty":-31.451576,"median":-14.562095,"eighty":41.997389,"marketCap":1122674562},{"date":"2025-01-24","current":-161.600486,"twenty":-32.125167,"median":-14.692664,"eighty":41.686231,"marketCap":1145909044},{"date":"2025-01-31","current":-163.995995,"twenty":-32.844617,"median":-14.754511,"eighty":41.125579,"marketCap":1162895599},{"date":"2025-02-07","current":-165.730674,"twenty":-33.21612,"median":-14.853009,"eighty":40.589491,"marketCap":1175196207},{"date":"2025-02-14","current":-162.977215,"twenty":-34.503504,"median":-14.943931,"eighty":39.583785,"marketCap":1155671432},{"date":"2025-02-21","current":-164.298875,"twenty":-35.196049,"median":-15.022224,"eighty":36.693359,"marketCap":1165043324},{"date":"2025-02-28","current":-150.283771,"twenty":-35.482914,"median":-15.15608,"eighty":35.417904,"marketCap":1065662219},{"date":"2025-03-07","current":-66.935633,"twenty":-35.801182,"median":-15.325295,"eighty":34.853341,"marketCap":1239781788},{"date":"2025-03-14","current":-67.379677,"twenty":-36.374044,"median":-15.537445,"eighty":34.638217,"marketCap":1248006384},{"date":"2025-03-21","current":-70.553775,"twenty":-36.543996,"median":-15.658673,"eighty":34.391425,"marketCap":1306797020},{"date":"2025-03-28","current":-74.950366,"twenty":-36.777718,"median":-15.830414,"eighty":33.702373,"marketCap":1388230680},{"date":"2025-04-04","current":-74.873618,"twenty":-37.127584,"median":-15.916284,"eighty":33.489434,"marketCap":1386809145}],"updateTime":1743960007202}}}